Molecular Health has appointed Christian Meisel as chief medical officer (CMO), effective immediately. In his new role, he will also be a member of the company’s leadership team.
Meisel joins Molecular Health from Roche where he served for more than 14 years in numerous senior leadership roles. He holds an MD from the Technical University of Munich, and a PhD from Charité Berlin, where he also served as associate professor and leader of a bioinformatics research group.
Friedrich von Bohlen, co-founder and CEO of Molecular Health, said: “We are very pleased to have Dr. Meisel join as our Chief Medical Officer. He not only is an experienced physician but, next to his background in computer science, also brings an extensive track record and expertise in precision medicine across the biopharmaceutical and diagnostics industry. With his broad experience in molecular diagnostics and drug development, he is a perfect addition to our development and commercial teams and will strategically enhance and further sharpen the focus of our offerings to pharma, physicians, providers, payers and the financial industry. The CMO position is key for our growth strategy, and we are happy to have found Christian for this important role at Molecular Health.”
